1 active not recruiting. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Active not recruiting 1 |
Follow afuresertib: new trials by email Literature Review of afuresertib trials Research Report on afuresertib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate Efficacy & Safety of Afuresertib Plus Fulvestrant in Patients With Locally Advanced or Metastatic HR+/HER2- Breast Cancer Afuresertib, Afuresertib/placebo - Breast Cancer | Phase 3 | Active not recruiting | Laekna Limited | 256 | 2022-02-18 | 2026-04-02 |
Breast Neoplasms (1)
Laekna Limited (1)
China (1) · United States (1)
Wenyue Ma (1)